pocketful logo light
pocketful logo light
Ambalal Sarabhai Enterprises Ltd logo

Ambalal Sarabhai Enterprises Ltd

NSE: AMBASARABH BSE: 500009

₹33.99

(0.21%)

Tue, 16 Jun 2026, 09:47 am

mtf coin illustrationMTF 5x

Ambalal Sarabhai Enterprises Share Price Live Chart

1 Day

(0.21%)

No Result Found

Summary

  • Market Cap (in Cr)

    273.5

  • Net Profit (in Cr)

    4.93

  • P/B

    1.92

  • Sector P/E

    33.76

  • P/E

    54.77

  • EV/EBITDA

    22.60

  • Debt/Equity (Industry)

    0.52

  • Interest Cover (Industry)

    40.83

  • ROCE (Industry)

    0.01

  • RONW (Industry)

    0.01

  • ROE

    6.05

  • ROCE

    8.87

  • Debt/Equity

    0.35

  • EPS (TTM)

    2.42

  • Dividend Yield

    0

  • Book Value

    20.66

  • Interest Cover

    3.55

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters31.3631.3631.3531.3531.35
FII00.340.340.380.38
DII0.010.010.010.010.10
Public68.6468.2968.3168.2768.17
Government00000

Read More

Technical Analysis

RSI

46.36

MACD

0.25

50 DMA

32.13

200 DMA

30.03

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic47.2540.6738.1834.0931.6027.5120.93
Fibonacci40.6738.1636.6034.0931.5830.0227.51
Camarilla37.5036.9036.2934.0935.0934.4833.88

Pivots Level: Classic

R3

+13.16

47.25

R2

+6.58

40.67

R1

+4.09

38.18

34.09
34.09
Pivot Point
LTP: 32.20

S1

-2.49

31.60

S2

-6.58

27.51

S3

-13.16

20.93

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    33.31

  • 20-EMA

    33.34

  • 30-EMA

    32.96

  • 50-EMA

    32.06

  • 100-EMA

    30.87

  • 200-EMA

    31.63

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
22 May 2026agm
21 May 2026board-meetingsAccounts, Quarterly Results, AGM
12 Feb 2026board-meetingsQuarterly Results
30 May 2025agm
24 May 2024agm
24 Aug 2023agm
17 Aug 2023egm
10 Aug 2022agm
11 Aug 2021agm

Read More

Peer Comparison

Ambalal Sarabhai Enterprises Ltd logo

Ambalal Sarabhai Enterprises Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Ambalal Sarabhai Enterprises Ltd About

Ambalal Sarabhai Enterprises is engaged in manufacturing Pharmaceuticals.

Industry

Trading

Founded

1977

Headquarters

CEO

Kartikeya V Sarabhai

Employees

Contact

Website icon

Website

http://www.ase.life

Email icon

Email

ase@sarabhai.co.in

Phone icon

Phone

91-79-25507671/25507073

Location icon

Location

Shanti Sadan, Mirzapur Road, Ahmedabad, Gujarat, 380001

Read More

Ambalal Sarabhai Enterprises Ltd Company History

YearHistory
2007
  • Ambalal Sarabhai Enterprises Ltd appointed Mr. B S Bohra as Additional Director of the Company.
2008
  • The Company acquired 100% paid-up share capital of Suvik Hi-tek Pvt. Ltd., making it a wholly owned subsidiary.
2012
  • Ms. Chaula Shastri joined the Board of Directors as a Whole-Time Director of the Company.
2016
  • The Company changed its registered office address from Sarabhai Campus Gorwa Road, Vadodara to Shanti Sadan Mirzapur Road, Ahmedabad.
2023
  • The Company launched new products 'Rapid Daignostics Product Range' A.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
MONET SECURITIES PRIVATE LTDbulkSell82159334.5718 Jun 2021
ALPHA LEON ENTERPRISES LLPbulkBuy44750734.1518 Jun 2021
TOPGAIN FINANCE PRIVATE LIMITEDbulkBuy39689134.8218 Jun 2021
ALPHA LEON ENTERPRISES LLPbulkSell44750735.7318 Jun 2021
TOPGAIN FINANCE PRIVATE LIMITEDbulkSell84792234.9118 Jun 2021
TOPGAIN FINANCE PRIVATE LIMITEDbulkBuy191531646.2110 Jun 2021
TOPGAIN FINANCE PRIVATE LIMITEDbulkSell83882247.3610 Jun 2021
TEJAS TRADEFIN LLPbulkBuy41029446.6710 Jun 2021
MANSI SHARE & STOCK ADVISORS PRIVATE LIMITEDbulkBuy87625246.7410 Jun 2021
TEJAS TRADEFIN LLPbulkSell30859447.5310 Jun 2021

Read More

Ambalal Sarabhai Enterprises Ltd News

Ambalal Sarabhai FY26 Net Profit Rises

Ambalal Sarabhai Enterprises reported a consolidated net profit of ₹1,780.32 lakh for FY26, up from ₹493.17 lakh in the previous year. Revenue from operations increased to ₹20,227.17 lakh.

21 May 2026

companies

Ambalal Sarabhai Board Meet Set for May 21, 2026

Ambalal Sarabhai Enterprises schedules Board Meeting on May 21, 2026 to approve audited financial results for Q4 and FY26, and fix AGM date.

14 May 2026

companies

Ambalal Sarabhai Submits SEBI Compliance Certificate

Ambalal Sarabhai Enterprises Limited filed mandatory certificate under SEBI Regulation 74(5) for period ended March 31, 2026, confirming proper dematerialization processes.

09 Apr 2026

companies

Ambalal Sarabhai Enterprises Reports Mixed Q2 Performance with Consolidated Loss Despite Revenue Growth

Ambalal Sarabhai Enterprises Limited reported consolidated revenue from operations of Rs 4,444.92 lakhs for the quarter ended September 30, 2025, compared to Rs 4,470.61 lakhs in the same period last year. The company posted a consolidated net loss of Rs 36.03 lakhs for the quarter versus a profit of Rs 261.99 lakhs in the previous year. For the half-year period, consolidated revenue reached Rs 8,478.80 lakhs with net profit of Rs 766.32 lakhs. On a standalone basis, the company recorded a loss of Rs 38.24 lakhs for the quarter. The company operates in two business segments - Pharmaceuticals and Electronics. Basic earnings per share stood at negative Rs 0.07 for the quarter. The Board of Directors approved these unaudited financial results in their meeting held on November 12, 2025.

12 Nov 2025

earnings

Ambalal Sarabhai Enterprises' Joint Venture CoSara Diagnostics Explores SPAC Transaction

Ambalal Sarabhai Enterprises Limited announced that Co-Diagnostics Inc., its joint venture partner in CoSara Diagnostics Pvt. Ltd., has engaged Maxim Group LLC as exclusive financial advisor to explore strategic alternatives for the Indian joint venture. The options include a potential merger with a Special Purpose Acquisition Company (SPAC) or similar entity listed on a U.S. national securities exchange. CoSara Diagnostics, established in 2017, is a joint venture between Co-Diagnostics Inc. and Synbiotics Ltd., with the latter being a group company of Asence Inc., both subsidiaries of Ambalal Sarabhai Enterprises. The joint venture focuses on manufacturing and selling molecular diagnostics products to patients and healthcare providers in international markets, with initial focus on India. Co-Diagnostics CEO Dwight Egan stated the company aims to unlock value for CoSara and shareholders while helping the venture realize its founding vision.

06 Nov 2025

order&deals

Read More

Open Your Free Demat Account

Enter your phone number